Literature DB >> 6512866

Cholinergic supersensitivity and decreased number of muscarinic receptors in atria from short-term diabetic rats.

G O Carrier, A D Edwards, R S Aronstam.   

Abstract

Autonomic neuropathy is a major complication of chronic diabetes and is responsible for disturbances in the cardiovascular system and other organs. Early cardiac disturbances have been attributed to defective vagal control of the heart. The heart rates of rats with chemically-induced diabetes are depressed and an increase in blood pressure produces a greater reflex bradycardia in diabetic rats. Tomlinson and Yusof found that isolated, stimulated left atria from rats made diabetic with alloxan are supersensitive to the negative inotropic influence of acetylcholine. On the other hand, Rao, et al. found that perfused working-heart preparations from streptozotocin- and alloxan-diabetic rats have a reduced sensitivity to carbamylcholine. In the present study, we measured chronotropic responses to cholinergic agonists of isolated, spontaneously-beating atria, as well as muscarinic receptor populations, in cardiac tissue from short-term (8 to 9 weeks) diabetic and age-matched control rats.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6512866     DOI: 10.1016/s0022-2828(84)80032-2

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  3 in total

1.  Prevalence of diabetes in elderly patients requiring permanent cardiac pacemaker insertion.

Authors:  J T Lear; I G Lawrence; A C Burden
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

2.  Prevalence of diabetes in elderly patients with pacemakers.

Authors:  J T Lear; I G Lawrence; A C Burden
Journal:  Postgrad Med J       Date:  1995-12       Impact factor: 2.401

3.  Effect of age and methacholine on the rate and coronary flow of isolated hearts of diabetic rats.

Authors:  X S Li; R D Tanz; K S Chang
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.